Atomo Diagnostics Limited (ASX: AT1) (Atomo) is pleased to announce that the Therapeutic Goods Administration (TGA) has approved its rapid SARS-CoV-2 antigen blood test for use by medical professionals in Australia.
Australian Therapeutic Goods Administration (TGA) has approved the AtomoRapid™ COVID-19 (IgG/IgM) test for inclusion on the ARTG for supply to departments of health, laboratories, medical practitioners and health care professionals in residential and aged care facilities
The only test we can buy from Atomo is the self-test for HIV
Atomo Diagnostics Limited (ASX: AT1) (Atomo) is pleased to...
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.10M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 2.0¢ | $1.244K | 61.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1627919 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 152000 | 2 |
View Market Depth
| Last trade - 15.45pm 09/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |